LEADER 02009nas 2200565- 450 001 9910146336603321 005 20241223110743.0 011 $a1687-6180 035 $a(OCoLC)133425278 035 $a(CKB)1000000000280479 035 $a(CONSER)--2008249018 035 $a(MiFhGG)48N4 035 $a(DE-599)ZDB2364203-8 035 $a(MiAaPQ)237299 035 $a(EXLCZ)991000000000280479 100 $a20070523a20079999 s-- - 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aEURASIP journal on advances in signal processing 210 1$c[Cairo, Egypt] :$cHindawi Pub. Corp. 210 31$aHeidelberg :$cSpringerOpen 215 $a1 online resource 300 $aAll issues originally published with the title: EURASIP journal on applied signal processing, have been reformatted and issued under the later title: EURASIP journal on advances in signal processing. 300 $aRefereed/Peer-reviewed 311 08$a1687-6172 517 3 $aEURASIP JASP 517 1 $aEuropean Association for Signal Processing journal on advances in signal processing 517 3 $aAdvances in signal processing 531 $aEURASIP J ADV SIG PR 531 $aJOURNAL ON ADVANCES IN SIGNAL PROCESSING 531 $aEURASIP J. ADV. SIGNAL PROCESS 531 $aEURASIP J ADV SIGNAL PROCESS 531 0 $aEURASIP J. Adv. Signal Process. 606 $aSignal processing$vPeriodicals 606 $aSignal processing 606 $aSignal processing$2fast$3(OCoLC)fst01118281 608 $aPeriodicals.$2lcgft 608 $aPeriodicals.$2fast 615 0$aSignal processing 615 0$aSignal processing. 615 7$aSignal processing. 712 02$aEuropean Association for Signal Processing, 712 02$aHindawi Publishing Corporation, 906 $aJOURNAL 912 $a9910146336603321 996 $aEURASIP Journal on Advances in Signal Processing$9794914 997 $aUNINA LEADER 04805nam 22006975 450 001 9910369953503321 005 20250610110342.0 010 $a3-030-02239-0 024 7 $a10.1007/978-3-030-02239-6 035 $a(CKB)4100000009273544 035 $a(DE-He213)978-3-030-02239-6 035 $a(MiAaPQ)EBC5896972 035 $a(PPN)258062657 035 $a(MiAaPQ)EBC29091033 035 $a(EXLCZ)994100000009273544 100 $a20190913d2020 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAnti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis /$fedited by Renato Alberto Sinico, Loïc Guillevin 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (X, 336 p. 52 illus., 35 illus. in color.) 225 1 $aRare Diseases of the Immune System,$x2282-6505 311 08$a3-030-02238-2 327 $aPreface -- 1 Introduction: Nomenclature and Classification -- 2 Epidemiology -- 3 Genetics -- 4 Pathogenesis B lymphocytes T lymphocytes -- 5 ANCA: methods and clinical significance -- 6 Activity and Damage -- 7 Eosinophilic Granulomatosis with Polyangiitis (EGPA) -- 8 Granulomatosis with Polyangiitis (GPA) -- 9 Microscopic Polyangiitis (MPA) -- 10 Vasculitis /organs involvement -- 11 ENT involvement -- 12 Lung involvement -- 13 Kidney involvement -- 14 Nervous system involvement. 15 Peripheral Nervous System -- 16 Central Nervous System -- 17 Skin involvement -- 18 Miscellaneous organ/system involvement (heart, gastrointestinal, articular?.) -- 19 Prognosis and outcome -- 20 Therapy -- Subject Index. 330 $aThis volume, written by well-known experts in the field, covers all aspects of Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV). The expression refers to a group of diseases, characterized by destruction and inflammation of small vessels. The clinical signs vary and affect several organs, such as the kidney, lung, skin, nervous system and others. The opening chapters give some historical hints, explain the genetic basis of the disease and provide insights into the pathogenesis derived from recent experimental studies and guides the reader through classification and nomenclature. A large part of the book is then devoted to a detailed description of the specific related diseases and their clinical presentations, the disease course, and potential complications. The advice regarding treatment is based on the best currently available evidence in this constantly evolving area. The book is part of Springer?s series Rare Diseases of the Immune System, which presents recently acquired knowledge on pathogenesis, diagnosis, and therapy with the aim of promoting a more holistic approach to these conditions. AAVs are systemic autoimmune diseases of unknown cause that affect small (to medium) sized blood vessels. They include granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (formerly Churg?Strauss syndrome). This volume will be an invaluable source of up-to-date information for all practitioners involved in the care of patients with these diseases. 410 0$aRare Diseases of the Immune System,$x2282-6505 606 $aRheumatology 606 $aNephrology 606 $aImmunology 606 $aInfectious diseases 606 $aOncology 606 $aRheumatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33170 606 $aNephrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33126 606 $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000 606 $aInfectious Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33096 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 615 0$aRheumatology. 615 0$aNephrology. 615 0$aImmunology. 615 0$aInfectious diseases. 615 0$aOncology. 615 14$aRheumatology. 615 24$aNephrology. 615 24$aImmunology. 615 24$aInfectious Diseases. 615 24$aOncology. 676 $a616.723 676 $a616.13 702 $aSinico$b Renato Alberto$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGuillevin$b Loïc$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910369953503321 996 $aAnti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis$92195568 997 $aUNINA